VitaDAO Raises $4.1M to Fund Early-Stage Longevity Research
• VitaDAO, a DeSci startup focused on longevity therapeutics, has raised $4.1 million in a token-based funding round led by Pfizer Ventures. • The funding will be used to further develop the platform, which focuses on funding early-stage longevity research and commercializing longevity therapeutics. • The round also included participation from Balaji Srinivasan, L1 Digital, …
VitaDAO Raises $4.1M to Fund Early-Stage Longevity Research Weiterlesen »